Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
REVENUE $ 4,209,000 $ 3,322,000
COST OF REVENUE 2,477,000 1,948,000
GROSS PROFIT 1,732,000 1,374,000
Operating Expenses [Abstract]    
Selling, marketing and advertising 2,277,000 2,650,000
Engineering, technology and development 1,699,000 2,956,000
General and administrative 2,102,000 2,520,000
Contingent consideration 259,000 468,000
Total operating expense 6,337,000 8,594,000
NET OPERATING LOSS (4,605,000) (7,220,000)
Nonoperating Income (Expense) [Abstract]    
Gain on sale of intangible assets 144,000 0
Change in fair value of warrant liability (761,000) 0
Interest expense (18,000) (40,000)
Other (20,000) 24,000
Total other income (expense) (655,000) (16,000)
Loss before benefit from income taxes (5,260,000) (7,236,000)
Benefit from income taxes 0 0
NET LOSS $ (5,260,000) $ (7,236,000)
Earnings Per Share [Abstract]    
Basic and diluted net loss per common share (in dollars per share) $ (1) $ (3.84)
Weighted-average number of shares outstanding, basic and diluted (in shares) 5,240,755 1,885,797